The current study suggested polyacetylene glycosides as promising leads for the dual inhibition of 5-LOX and BchE enzymes, which could be applied for the prevention and treatment of neuroinflammatory disorders, such as Alzheimer’s disease. The gene discussed is ALOX5; the disease is early-onset autosomal dominant Alzheimer disease.